By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The UK needs to start developing a plan to review its policies and practices regarding DNA and biomarker patents and how these programs are monitored and managed, according to a new report issued by the Human Genetics Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.